BICC1: A Potential Drug Target and Biomarker (G80114)

Target Name: BICC1

NCBI ID: G80114

BICC1

BICC1: A Potential Drug Target and Biomarker

Introduction

Bic uracil nucleotide single-chain binding protein-1 (BICC1) is a protein that is expressed in various tissues and cell types in the human body. BICC1 has been identified as a potential drug target and biomarker due to its unique structure and various cellular functions. In this article, we will discuss the properties of BICC1, its potential as a drug target, and its potential as a biomarker for various diseases.

Structure and Function

BICC1 is a protein that consists of 114 amino acid residues. It has a unique structure that includes consensus a long N-terminus, a conserved deduced region, and a C-terminus that is rich in conserved secondary structure. The N-terminus of BICC1 contains a putative N-glycosylation site, which is important for protein-protein interactions and may play a role in BICC1's function. The deduced consensus region of BICC1 includes a conserved alpha-helix and a beta-sheet, which may contribute to BICC1's stability and functions. The C-terminus of BICC1 is rich in conserved structural features, including a conserved lysine residue, a conserved arginine residue, and a conserved glycine residue, which may contribute to BICC1's stability and functions.

BICC1 is involved in various cellular processes, including DNA replication, transcription, and repair, cell adhesion, and cell signaling. BICC1 has also been shown to play a role in regulating cell cycle progression, cell adhesion, and apoptosis. play a role in the regulation of gene expression, including the regulation of stem cell proliferation and the regulation of cancer cell growth.

Potential Drug Target

BICC1 has been identified as a potential drug target due to its unique structure and various cellular functions. BICC1 has been shown to interact with various signaling pathways, including the PI3K/Akt signaling pathway, the NF-kappa-B signaling pathway, and the TGF-β signaling pathway. BICC1 has also been shown to play a role in the regulation of cellular processes, including cell cycle progression, cell adhesion, and apoptosis.

Due to its unique structure and various cellular functions, BICC1 has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. BICC1 has also been shown to be a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

Potential Biomarkers

BICC1 has also been shown to be involved in the regulation of gene expression, including the regulation of stem cell proliferation and the regulation of cancer cell growth. due to its unique structure and various cellular functions, BICC1 has been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

Conclusion

BICC1 is a protein that consists of 114 amino acid residues and has a unique structure that includes a long N-terminus, a conserved deduced consensus region, and a C-terminus that is rich in conserved structural features. BICC1 is involved in various cellular processes , including DNA replication, transcription, and repair, cell adhesion, and cell signaling. Additionally, BICC1 has been shown to play a role in regulating cell cycle progression, cell adhesion, and apoptosis, as well as the regulation of gene expression.

Due to its unique structure and various cellular functions, BICC1 has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Additionally, BICC1 has been shown to be a potential biomarker for various diseases, including cancer. , neurodegenerative diseases, and cardiovascular diseases. Further research is needed to fully understand the properties of BICC1 and its potential as a drug target and biomarker.

Protein Name: BicC Family RNA Binding Protein 1

Functions: Putative RNA-binding protein. Acts as a negative regulator of Wnt signaling. May be involved in regulating gene expression during embryonic development

The "BICC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BICC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets